Literature DB >> 30715980

Qualifying Conditions Of Medical Cannabis License Holders In The United States.

Kevin F Boehnke1, Saurav Gangopadhyay2, Daniel J Clauw3, Rebecca L Haffajee4.   

Abstract

The evidence for cannabis's treatment efficacy across different conditions varies widely, and comprehensive data on the conditions for which people use cannabis are lacking. We analyzed state registry data to provide nationwide estimates characterizing the qualifying conditions for which patients are licensed to use cannabis medically. We also compared the prevalence of medical cannabis qualifying conditions to recent evidence from the National Academies of Sciences, Engineering, and Medicine report on cannabis's efficacy in treating each condition. Twenty states and the District of Columbia had available registry data on patient numbers, and fifteen states had data on patient-reported qualifying conditions. Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (64.9 percent in 2016). Of all patient-reported qualifying conditions, 85.5 percent had either substantial or conclusive evidence of therapeutic efficacy. As medical cannabis use continues to increase, creating a nationwide patient registry would facilitate better understanding of trends in use and of its potential effectiveness.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30715980      PMCID: PMC6398594          DOI: 10.1377/hlthaff.2018.05266

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  25 in total

1.  Do medical marijuana laws reduce addictions and deaths related to pain killers?

Authors:  David Powell; Rosalie Liccardo Pacula; Mireille Jacobson
Journal:  J Health Econ       Date:  2018-02-03       Impact factor: 3.883

2.  Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups?

Authors:  Sharon R Sznitman
Journal:  Int J Drug Policy       Date:  2017-01-18

3.  States Move to Substitute Opioids With Medical Marijuana to Quell Epidemic.

Authors:  Rebecca Voelker
Journal:  JAMA       Date:  2018-12-18       Impact factor: 56.272

4.  Trends in registered medical marijuana participation across 13 US states and District of Columbia.

Authors:  Brian J Fairman
Journal:  Drug Alcohol Depend       Date:  2015-11-22       Impact factor: 4.492

5.  Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep.

Authors:  Brian J Piper; Rebecca M DeKeuster; Monica L Beals; Catherine M Cobb; Corey A Burchman; Leah Perkinson; Shayne T Lynn; Stephanie D Nichols; Alexander T Abess
Journal:  J Psychopharmacol       Date:  2017-04-04       Impact factor: 4.153

6.  Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever.

Authors:  Yuyan Shi
Journal:  Drug Alcohol Depend       Date:  2017-02-21       Impact factor: 4.492

7.  Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample.

Authors:  Lewei A Lin; Mark A Ilgen; Mary Jannausch; Kipling M Bohnert
Journal:  Addict Behav       Date:  2016-05-17       Impact factor: 3.913

8.  Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.

Authors:  Hefei Wen; Jason M Hockenberry
Journal:  JAMA Intern Med       Date:  2018-05-01       Impact factor: 21.873

9.  Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D.

Authors:  Ashley C Bradford; W David Bradford
Journal:  Health Aff (Millwood)       Date:  2016-07-01       Impact factor: 6.301

10.  A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy.

Authors:  Michelle Sexton; Carrie Cuttler; John S Finnell; Laurie K Mischley
Journal:  Cannabis Cannabinoid Res       Date:  2016-06-01
View more
  43 in total

Review 1.  Occupational Allergies to Cannabis.

Authors:  Ine I Decuyper; Brett J Green; Gordon L Sussman; Didier G Ebo; William S Silvers; Karin Pacheco; Bradley S King; John R Cohn; Robert S Zeiger; Joanna S Zeiger; David R Naimi; Donald H Beezhold; Ajay P Nayak
Journal:  J Allergy Clin Immunol Pract       Date:  2020 Nov - Dec

2.  High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain.

Authors:  Kevin F Boehnke; J Ryan Scott; Evangelos Litinas; Suzanne Sisley; David A Williams; Daniel J Clauw
Journal:  J Pain       Date:  2019-09-24       Impact factor: 5.820

Review 3.  Medical cannabis for chronic pain: can it make a difference in pain management?

Authors:  Mari Kannan Maharajan; Yu Jing Yong; Hong Yang Yip; Sze Shee Woon; Kar Mon Yeap; Khai Yeng Yap; Shuen Chi Yip; Kai Xian Yap
Journal:  J Anesth       Date:  2019-09-18       Impact factor: 2.078

4.  Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.

Authors:  Sabrina L Botsford; Sharon Yang; Tony P George
Journal:  Am J Addict       Date:  2019-10-02

5. 

Authors:  Rejina Kamrul; Debbie Bunka; Alex Crawley; Brenda Schuster; Marlys LeBras
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

6.  Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights.

Authors:  Rejina Kamrul; Debbie Bunka; Alex Crawley; Brenda Schuster; Marlys LeBras
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

7.  Ensuring access to safe, effective, and affordable cannabis-based medicines.

Authors:  Jennifer H Martin; Wayne Hall; Mary-Ann Fitzcharles; Laura Borgelt; Jose Crippa
Journal:  Br J Clin Pharmacol       Date:  2020-03-03       Impact factor: 4.335

Review 8.  Care of the Patient Using Cannabis.

Authors:  Arthur Robin Williams; Kevin P Hill
Journal:  Ann Intern Med       Date:  2020-11-03       Impact factor: 25.391

9.  [Cannabis medicines in pain management : Interim analysis of the survey accompanying the prescription of cannabis-based medicines in Germany with regard to pain as primarily treated symptom].

Authors:  P Cremer-Schaeffer; G Schmidt-Wolf; K Broich
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

10.  State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress.

Authors:  Ryan K McBain; Eunice C Wong; Joshua Breslau; Amy L Shearer; Matthew S Cefalu; Elizabeth Roth; M Audrey Burnam; Rebecca L Collins
Journal:  Drug Alcohol Depend       Date:  2020-07-24       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.